rs104894090
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000349.3(STAR):c.562C>T(p.Arg188Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000471 in 1,614,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000049 ( 0 hom. )
Consequence
STAR
NM_000349.3 missense
NM_000349.3 missense
Scores
16
2
1
Clinical Significance
Conservation
PhyloP100: 4.20
Genes affected
STAR (HGNC:11359): (steroidogenic acute regulatory protein) The protein encoded by this gene plays a key role in the acute regulation of steroid hormone synthesis by enhancing the conversion of cholesterol into pregnenolone. This protein permits the cleavage of cholesterol into pregnenolone by mediating the transport of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane. Mutations in this gene are a cause of congenital lipoid adrenal hyperplasia (CLAH), also called lipoid CAH. A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a domain START (size 213) in uniprot entity STAR_HUMAN there are 5 pathogenic changes around while only 2 benign (71%) in NM_000349.3
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.956
PP5
Variant 8-38146051-G-A is Pathogenic according to our data. Variant chr8-38146051-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 8997.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-38146051-G-A is described in Lovd as [Likely_pathogenic]. Variant chr8-38146051-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STAR | ENST00000276449.9 | c.562C>T | p.Arg188Cys | missense_variant | 5/7 | 1 | NM_000349.3 | ENSP00000276449.3 | ||
STAR | ENST00000522050.1 | c.496C>T | p.Arg166Cys | missense_variant | 4/5 | 5 | ENSP00000429009.1 | |||
STAR | ENST00000520114.1 | n.1049C>T | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152216Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152216
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251352Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135900
GnomAD3 exomes
AF:
AC:
11
AN:
251352
Hom.:
AF XY:
AC XY:
8
AN XY:
135900
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.0000646 AC XY: 47AN XY: 727246
GnomAD4 exome
AF:
AC:
72
AN:
1461886
Hom.:
Cov.:
32
AF XY:
AC XY:
47
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74370
GnomAD4 genome
AF:
AC:
4
AN:
152216
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
7
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Congenital lipoid adrenal hyperplasia due to STAR deficency Pathogenic:8
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 15, 2024 | Variant summary: STAR c.562C>T (p.Arg188Cys) results in a non-conservative amino acid change located in the START domain (IPR002913) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.4e-05 in 251552 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in STAR causing Congenital Lipoid Adrenal Hyperplasia (4.4e-05 vs 0.0035), allowing no conclusion about variant significance. c.562C>T has been reported in the literature in multiple bi-allelic individuals affected with Congenital Lipoid Adrenal Hyperplasia (examples: Baker_2006, Sahakitrungruang_2010, Fluck_2011, Zhang_2021). These data indicate that the variant is very likely to be associated with disease. Multiple publications have reported experimental evidence that this variant disrupts normal protein activity (Baker_2006 and Sahakitrungruang_2010). The following publications have been ascertained in the context of this evaluation (PMID: 16968793, 20444910, 33227378, 21691943, 21951701). ClinVar contains an entry for this variant (Variation ID: 8997). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 25, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Sep 26, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The observed missense c.562C>T(p.Arg188Cys) variant in STAR gene has been reported previously in homozygous or compound heterozygous state in individual(s) affected with Lipoid adrenal hyperplasia (Lu et al., 2022). Experimental studies have shown that this missense change affects STAR function (Sahakitrungruang et al., 2010). This variant is reported with the allele frequency of 0.004% in the gnomAD Exomes. This variant has been reported to the ClinVar database as Pathogenic (multiple submitters). The amino acid Arg at position 188 is changed to a Cys changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Arg188Cys in STAR is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The variant is predicted as damaging by SIFT. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2006 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 03, 2022 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 14, 2023 | Published functional studies demonstrate decreased binding to cholesterol and reduced enzymatic activity (Baker et al., 2006); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34758253, 20444910, 26650942, 28637490, 17301050, 29576868, 34426522, 32841165, 33227378, 16968793, 19773404) - |
Pathogenic, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The STAR p.R188C variant was identified in the literature in individuals and families with nonclassic lipoid congenital adrenal hyperplasia, chronic adrenal insufficiency, and primary/acute adrenal insufficiency in the homozygous or compound heterozygous state (Baker_2006_PMID:16968793; Metherell_2009_PMID:19773404; Sahakitrungruang_2011_PMID: 20444910; Tsai_2015_PMID:26650942; Bizzarri_2017_PMID:28637490; Burget_2018_PMID:29576868). The variant was identified in dbSNP (ID: rs104894090), LOVD 3.0 (classified as likely pathogenic) and ClinVar (classified as pathogenic by Counsyl, Invitae, and OMIM, and associated with cholesterol monooxygenase (side-chain cleaving) deficiency and lipoid congenital adrenal hyperplasia). The variant was identified in control databases in 11 of 251352 chromosomes at a frequency of 0.00004376 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 8 of 30616 chromosomes (freq: 0.000261), African in 1 of 16244 chromosomes (freq: 0.000062) and European (non-Finnish) in 2 of 113662 chromosomes (freq: 0.000018), but was not observed in the Latino, Ashkenazi Jewish, East Asian, European (Finnish), or Other populations. The variant occurs outside of the splicing consensus sequence and three of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. However, the p.Arg188 residue is conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the variant may impact the protein. Further, functional studies of the STAR p.R188C mutant protein have demonstrated reduced protein activity and cholesterol-binding capacity (Baker_2006_PMID:16968793; Sahakitrungruang_2011_PMID: 20444910). In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 188 of the STAR protein (p.Arg188Cys). This variant is present in population databases (rs104894090, gnomAD 0.03%). This missense change has been observed in individuals with nonclassic lipoid congenital adrenal hyperplasia or primary adrenal insufficiency (PMID: 16968793, 19773404, 20444910, 26650942, 28637490, 29576868). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8997). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt STAR protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects STAR function (PMID: 16968793, 20444910). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at